AMGEN - BE 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 10.459.997 0 1
2017 0 23.749.833 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ABBVIE INC2
CELGENE MANAGEMENT SARL2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
F HOFFMANNLA ROCHE2
GMV SOLUCIONES GLOBALES INTERNET SAU2
JANSSEN PHARMACEUTICA NV2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
NOVARTIS PHARMA2
PFIZER LIMITED2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
ARTTIC INNOVATION1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION EISBM1
ASTRAZENECA1
BARTS AND THE LONDON NHS TRUST1
BAYER1
BAYER AKTIENGESELLSCHAFT1
BAYER PHARMA1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
DEUTSCHE KREBSGESELLSCHAFT EV1
ELI LILLY AND COMPANY LIMITED1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROPEAN LUNG FOUNDATION1
EUROPEAN RESEARCH INITIATIVE ON CLL EV1
EUROPEAN RESPIRATORY SOCIETY1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FOLKEHELSEINSTITUTTET1
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
FUNDACION HOSPITAL LA FE1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
GENOME RESEARCH1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GPOH GEMEINNUTZIGE1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA1
GROUPE FRANCOPHONE DES MYELODYSPLASIES1
HEALTH IQ LIMITED1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HELIOS KLINIKUM EMIL VON BEHRING1
HELMHOLTZZENTRUM DRESDENROSSENDORF EV1
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSTITUT DE CANCEROLOGIE DE L'OUEST1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INTERSYSTEMS1
ISTITUTO EUROPEO DI ONCOLOGIA1
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN1
LEUKANET EV1
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE1
LUND UNIVERSITY1
LUNGS EUROPE1
MASARYKOVA UNIVERZITA1
MEDISAPIENS OY1
MEDIZINISCHE UNIVERSITAET WIEN1
MENARINI RICERCHE1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MLL MUNCHNER LEUKAMIELABOR1
MUTABOR TECHNOLOGIES1
NOVO NORDISK1
OSPEDALE PEDIATRICO BAMBINO GESU1
OWKIN FRANCE1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
SEMMELWEIS EGYETEM1
SMART REPORTING1
STATENS LEGEMIDDELVERK1
STICHTING EUROPEAN UROLOGICAL FOUNDATION1
STICHTING VUMC1
STIFTUNG ELN FOUNDATION1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TANDVARDSOCH LAKEMEDELSFORMANSVERKET1
TARTU ULIKOOL1
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL1
THE LYMPHOMA STUDY ASSOCIATION1
THE UNIVERSITY OF LIVERPOOL1
TMF TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV1
TTOPSTART BV1
UCB BIOPHARMA1
UNIVERSIDAD DE NAVARRA1
UNIVERSITA COMMERCIALE LUIGI BOCCONI1
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITA VITASALUTE SAN RAFFAELE1

Constancy:

Total number of partners: 125
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 125
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-10-01Optimal treatment for patients with solid tumours in Europe through Artificial intelligence OPTIMAparticipant10.459.99739
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053